Stem Cell Therapy For Infertility Market Report 2026

Stem Cell Therapy For Infertility Market Overview

• Stem Cell Therapy For Infertility market size has reached to $1.87 billion in 2025 • Expected to grow to $3.99 billion in 2030 at a compound annual growth rate (CAGR) of 16.4% • Growth Driver: Surge In Infertility Cases Fueling Growth Due To Delayed Childbearing And Increasing Demand For Advanced Fertility Treatments • Market Trend: Advancements In Ipsc-Based Regenerative Therapies Driving Personalized Treatment Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Stem Cell Therapy For Infertility Market?

Stem cell therapy for infertility refers to an advanced regenerative treatment approach that utilizes stem cells to restore or enhance the function of reproductive tissues and organs in both males and females. It aims to repair damaged ovarian, testicular, or endometrial tissues, improve gamete quality, and promote hormonal balance. The main components of stem cell therapy for infertility are male infertility treatment, female infertility treatment. Stem cell therapy for male infertility is a regenerative treatment that uses stem cells to restore or improve sperm production and overall reproductive function in men with impaired fertility. The various treatment types include autologous stem cell therapy, allogeneic stem cell therapy, combination therapy. The cell source includes embryonic stem cells, adult stem cells, induced pluripotent stem cells. The applications include ovarian insufficiency, uterine infertility, genetic disorders. The various end-users include hospitals, specialty clinics, research institutes.

What Is The Stem Cell Therapy For Infertility Market Growth Forecast?

The stem cell therapy for infertility market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to increasing clinical validation of stem cell infertility treatments, rising investments in reproductive regenerative medicine, growing acceptance of personalized fertility solutions, expansion of clinical trials in reproductive health, increasing collaboration between fertility clinics and research institutions. Major trends in the forecast period include increasing focus on ovarian and testicular regeneration therapies, rising use of autologous stem cell treatments, growing integration with assisted reproductive technologies, expansion of personalized fertility treatment protocols, enhanced clinical research in reproductive regeneration.

Global Stem Cell Therapy For Infertility Market Segmentation

1) By Type: Male Infertility Treatment, Female Infertility Treatment 2) By Treatment Type: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy, Combination Therapy 3) By Cell Source: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells 4) By Application: Ovarian Insufficiency, Uterine Infertility, Genetic Disorders 5) By End User: Hospitals, Specialty Clinics, Research Institutes Subsegments: 1) By Male Infertility Treatment: Surgical Sperm Retrieval, Hormonal Therapy, Stem Cell Transplantation, Assisted Reproductive Techniques 2) By Female Infertility Treatment: Ovarian Stem Cell Therapy, Endometrial Regeneration Therapy, Hormonal Therapy, In Vitro Fertilization Enhancement

What Is The Driver Of The Stem Cell Therapy For Infertility Market?

The rising cases of infertility are expected to contribute significantly to the growth of the stem cell therapy for infertility market going forward. Infertility refers to the inability of a couple to conceive after 12 months or more of regular unprotected sexual intercourse. The increasing prevalence of infertility is largely attributed to delayed childbearing, as many individuals choose to have children later in life, resulting in reduced fertility due to the natural decline in reproductive potential with age, particularly among women. Stem cell therapy for infertility offers promising solutions by regenerating damaged reproductive tissues, improving ovarian and testicular function, and enhancing the chances of conception. For instance, in April 2023, according to a report published by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, infertility affects approximately 17.5% of the adult population, or about 1 in 6 people globally, highlighting the growing need to expand access to affordable and high-quality fertility care. Therefore, the rising cases of infertility are expected to drive the expansion of the stem cell therapy for infertility industry.

Key Players In The Global Stem Cell Therapy For Infertility Market

Major companies operating in the stem cell therapy for infertility market are PlacidWay LLC, New Life India Fertility Clinic Private Limited, Jeevan Mithra Fertility Centre Private Limited, Equipo IVI S.L., Hope Fertility & Stem Cell Centre Pvt. Ltd., Bioscience Institute SpA, Advancells Dermaceuticals Private Limited, GIOSTAR INDIA PRIVATE LIMITED, Shree IVF Clinic Private Limited, Stem Cells Care (india) Private Limited, GenCell Ltd., StemRx BioScience Solutions Private Limited., Kiran Infertility Centre Private Limited, R3 Stem Cell LLC., Bavishi Fertility Institute Private Limited, Seragen Biotherapeutics Private Limited, Esha IVF Fertility Centre Private Limited, Embryonic Tissue Center EmCell, InoCells B.V., Vega Stem Cell Clinic Co. Ltd.

Global Stem Cell Therapy For Infertility Market Trends and Insights

Major companies operating in the stem cell therapy for infertility market are focusing on advancements in stem cell technologies, such as induced pluripotent stem cells (iPSCs), to enhance personalized regenerative treatments, improve patient-specific outcomes, and expand the range of treatable reproductive conditions. Induced pluripotent stem cells are adult somatic cells that have been genetically reprogrammed to an embryonic-like pluripotent state, enabling them to differentiate into virtually any cell type in the body. For instance, in January 2025, Gameto Inc., a US-based biotechnology company, initiated a pivotal Phase III clinical trial for its iPSC-derived fertility therapy, Fertilo, following Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA). The trial, spanning approximately 15 sites across the U.S., aims to evaluate egg maturation outside the body using engineered ovarian support cells, potentially shortening IVF cycles and reducing hormonal stimulation by up to 80%. If successful, this will represent the first late-stage clinical program for an in-vitro matured egg therapy derived from induced pluripotent stem cells in the treatment of infertility.

What Are Latest Mergers And Acquisitions In The Stem Cell Therapy For Infertility Market?

In October 2023, REPROCELL Inc., a Japan‑based biotechnology company, acquired Gameto, Inc., for an undisclosed amount. Through this acquisition, REPROCELL Inc. aims to strengthen its position in the fertility and regenerative medicine sector by integrating Gameto, Inc.'s advanced iPSC-based fertility technologies to accelerate the development of innovative treatments for infertility. Gameto Inc. is a U.S.-based biotechnology company that provides stem cell therapy for infertility.

Regional Outlook

North America was the largest region in the stem cell therapy for infertility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Stem Cell Therapy For Infertility Market?

The stem cell therapy for infertility market includes revenues earned by providing services such as fertility restoration therapy services, clinical research support services, biobanking of stem cell services, allogeneic stem cell transplantation services, and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Stem Cell Therapy For Infertility Market Report 2026?

The stem cell therapy for infertility market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell therapy for infertility industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.